224 related articles for article (PubMed ID: 25005682)
1. Cell-permeable protein therapy for complex I dysfunction.
Pepe S; Mentzer RM; Gottlieb RA
J Bioenerg Biomembr; 2014 Aug; 46(4):337-45. PubMed ID: 25005682
[TBL] [Abstract][Full Text] [Related]
2. Xenotransplantation of mitochondrial electron transfer enzyme, Ndi1, in myocardial reperfusion injury.
Perry CN; Huang C; Liu W; Magee N; Carreira RS; Gottlieb RA
PLoS One; 2011 Feb; 6(2):e16288. PubMed ID: 21339825
[TBL] [Abstract][Full Text] [Related]
3. Gene Therapy with Single-Subunit Yeast NADH-Ubiquinone Oxidoreductase (NDI1) Improves the Visual Function in Experimental Autoimmune Encephalomyelitis (EAE) Mice Model of Multiple Sclerosis (MS).
Talla V; Koilkonda R; Guy J
Mol Neurobiol; 2020 Apr; 57(4):1952-1965. PubMed ID: 31900864
[TBL] [Abstract][Full Text] [Related]
4. Possibility of transkingdom gene therapy for complex I diseases.
Yagi T; Seo BB; Nakamaru-Ogiso E; Marella M; Barber-Singh J; Yamashita T; Matsuno-Yagi A
Biochim Biophys Acta; 2006; 1757(5-6):708-14. PubMed ID: 16581014
[TBL] [Abstract][Full Text] [Related]
5. Gene therapy of yeast NDI1 on mitochondrial complex I dysfunction in rotenone-induced Parkinson's disease models in vitro and vivo.
Li H; Sun B; Huang Y; Zhang J; Xu X; Shen Y; Chen Z; Yang J; Shen L; Hu Y; Gu H
Mol Med; 2022 Mar; 28(1):29. PubMed ID: 35255803
[TBL] [Abstract][Full Text] [Related]
6. Can a single subunit yeast NADH dehydrogenase (Ndi1) remedy diseases caused by respiratory complex I defects?
Yagi T; Seo BB; Nakamaru-Ogiso E; Marella M; Barber-Singh J; Yamashita T; Kao MC; Matsuno-Yagi A
Rejuvenation Res; 2006; 9(2):191-7. PubMed ID: 16706641
[TBL] [Abstract][Full Text] [Related]
7. Parkinson's disease and mitochondrial complex I: a perspective on the Ndi1 therapy.
Marella M; Seo BB; Yagi T; Matsuno-Yagi A
J Bioenerg Biomembr; 2009 Dec; 41(6):493-7. PubMed ID: 19904590
[TBL] [Abstract][Full Text] [Related]
8. Reaction mechanism of single subunit NADH-ubiquinone oxidoreductase (Ndi1) from Saccharomyces cerevisiae: evidence for a ternary complex mechanism.
Yang Y; Yamashita T; Nakamaru-Ogiso E; Hashimoto T; Murai M; Igarashi J; Miyoshi H; Mori N; Matsuno-Yagi A; Yagi T; Kosaka H
J Biol Chem; 2011 Mar; 286(11):9287-97. PubMed ID: 21220430
[TBL] [Abstract][Full Text] [Related]
9. Functional expression of the single subunit NADH dehydrogenase in mitochondria in vivo: a potential therapy for complex I deficiencies.
Seo BB; Nakamaru-Ogiso E; Cruz P; Flotte TR; Yagi T; Matsuno-Yagi A
Hum Gene Ther; 2004 Sep; 15(9):887-95. PubMed ID: 15353043
[TBL] [Abstract][Full Text] [Related]
10. Differential Effects of Yeast NADH Dehydrogenase (Ndi1) Expression on Mitochondrial Function and Inclusion Formation in a Cell Culture Model of Sporadic Parkinson's Disease.
Cronin-Furman EN; Barber-Singh J; Bergquist KE; Yagi T; Trimmer PA
Biomolecules; 2019 Mar; 9(4):. PubMed ID: 30934776
[TBL] [Abstract][Full Text] [Related]
11. New complexes containing the internal alternative NADH dehydrogenase (Ndi1) in mitochondria of Saccharomyces cerevisiae.
Matus-Ortega MG; Cárdenas-Monroy CA; Flores-Herrera O; Mendoza-Hernández G; Miranda M; González-Pedrajo B; Vázquez-Meza H; Pardo JP
Yeast; 2015 Oct; 32(10):629-41. PubMed ID: 26173916
[TBL] [Abstract][Full Text] [Related]
12. Reduction of infarct size by the therapeutic protein TAT-Ndi1 in vivo.
Mentzer RM; Wider J; Perry CN; Gottlieb RA
J Cardiovasc Pharmacol Ther; 2014 May; 19(3):315-20. PubMed ID: 24367006
[TBL] [Abstract][Full Text] [Related]
13. Lack of complex I activity in human cells carrying a mutation in MtDNA-encoded ND4 subunit is corrected by the Saccharomyces cerevisiae NADH-quinone oxidoreductase (NDI1) gene.
Bai Y; Hájek P; Chomyn A; Chan E; Seo BB; Matsuno-Yagi A; Yagi T; Attardi G
J Biol Chem; 2001 Oct; 276(42):38808-13. PubMed ID: 11479321
[TBL] [Abstract][Full Text] [Related]
14. Expression of yeast NDI1 rescues a Drosophila complex I assembly defect.
Cho J; Hur JH; Graniel J; Benzer S; Walker DW
PLoS One; 2012; 7(11):e50644. PubMed ID: 23226344
[TBL] [Abstract][Full Text] [Related]
15. Intravitreal delivery of AAV-NDI1 provides functional benefit in a murine model of Leber hereditary optic neuropathy.
Chadderton N; Palfi A; Millington-Ward S; Gobbo O; Overlack N; Carrigan M; O'Reilly M; Campbell M; Ehrhardt C; Wolfrum U; Humphries P; Kenna PF; Farrar GJ
Eur J Hum Genet; 2013 Jan; 21(1):62-8. PubMed ID: 22669418
[TBL] [Abstract][Full Text] [Related]
16. Neuroprotective effect of long-term NDI1 gene expression in a chronic mouse model of Parkinson disorder.
Barber-Singh J; Seo BB; Nakamaru-Ogiso E; Lau YS; Matsuno-Yagi A; Yagi T
Rejuvenation Res; 2009 Aug; 12(4):259-67. PubMed ID: 19653878
[TBL] [Abstract][Full Text] [Related]
17. Yeast NDI1 reconfigures neuronal metabolism and prevents the unfolded protein response in mitochondrial complex I deficiency.
Granat L; Knorr DY; Ranson DC; Hamer EL; Chakrabarty RP; Mattedi F; Fort-Aznar L; Hirth F; Sweeney ST; Vagnoni A; Chandel NS; Bateman JM
PLoS Genet; 2023 Jul; 19(7):e1010793. PubMed ID: 37399212
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic applications of the TAT-mediated protein transduction system for complex I deficiency and other mitochondrial diseases.
Lin BY; Kao MC
Ann N Y Acad Sci; 2015 Sep; 1350():17-28. PubMed ID: 26273800
[TBL] [Abstract][Full Text] [Related]
19. In vivo complementation of complex I by the yeast Ndi1 enzyme. Possible application for treatment of Parkinson disease.
Seo BB; Nakamaru-Ogiso E; Flotte TR; Matsuno-Yagi A; Yagi T
J Biol Chem; 2006 May; 281(20):14250-5. PubMed ID: 16543240
[TBL] [Abstract][Full Text] [Related]
20. Modulation of oxidative phosphorylation of human kidney 293 cells by transfection with the internal rotenone-insensitive NADH-quinone oxidoreductase (NDI1) gene of Saccharomyces cerevisiae.
Seo BB; Matsuno-Yagi A; Yagi T
Biochim Biophys Acta; 1999 May; 1412(1):56-65. PubMed ID: 10354494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
